Opportunity

Liverpool Flexible Lab and Grow-On Network

Life-science spinouts need compliant laboratory space, shared equipment, write-up space and flexible terms before they have the balance sheet or headcount for a conventional lease.

Decision snapshot

Primary user
- University, hospital and research-institute spinouts needing their first commercial lab. - Life-science scaleups between shared bench and institutional headquarters.
Why now
- A quantified 46,100 square metre R&D gap is unusually direct property-market evidence. - A live regional funding call specifically targets the required lab types and startup growth.
Initial wedge
A managed network of modular Category 1/2-ready labs and write-up space in partner buildings. Members can start with a bench or small private suite, book shared equipment, access waste and consumables services, and move across the network as they grow.
Key uncertainty
Evidence 25/25 + severity 18/20 + buyer urgency 16/20 + market gap 12/15 + timing 9/10 + delivery feasibility 5/10 = 85/100.

The problem

Life-science spinouts need compliant laboratory space, shared equipment, write-up space and flexible terms before they have the balance sheet or headcount for a conventional lease. A team that outgrows an incubator can face a binary choice between expensive bespoke fit-out, waiting for a major building or relocating to another cluster.

Liverpool's employment evidence identifies a 46,100 square metre residual R&D shortfall and specifically calls for spinout and grow-on space. Delivering new speculative lab buildings is difficult because fit-out is capital intensive and the wider viability assessment finds speculative offices unviable. The opportunity is therefore an operator model that activates smaller suites and shared facilities across multiple assets, not only another large development.

Who is underserved

- University, hospital and research-institute spinouts needing their first commercial lab. - Life-science scaleups between shared bench and institutional headquarters. - Principal investigators and project teams needing short-term overflow capacity. - Landlords with buildings that can support laboratory conversion but lack specialist operations. - Liverpool institutions seeking to retain companies as research is commercialised.

Evidence

Local evidence: - Liverpool's Employment Land and Premises Study recommends up to 53,200 square metres of R&D need and identifies a residual shortfall of approximately 46,100 square metres after existing supply. - The study says growth potential depends on university spinouts and grow-on space, with the Knowledge Quarter as the principal R&D location. - The Combined Authority is seeking investment proposals for new or refurbished Category 1 or 2 laboratories, clean rooms and write-up space, requiring at least 40% of total floorspace for lab or clean-room use.

Price evidence: - A UK flexible-lab benchmark advertises shared laboratory space from £1,400 per month per dedicated bench, demonstrating a recurring small-team price point.

Commercial implication: - Public gap funding plus recurring memberships can support an asset-light operator working with existing landlords.

Demand

- A quantified 46,100 square metre R&D gap is unusually direct property-market evidence. - A live regional funding call specifically targets the required lab types and startup growth. - Local universities, hospitals and the Investment Zone create a concentrated referral network. - Existing UK shared labs demonstrate that bench-level subscription pricing is accepted.

Competition

Sciontec and Sci-Tech Daresbury are important local providers; Bruntwood, Pioneer Group, Science Creates and other operators serve UK clusters. Planned Liverpool buildings may absorb some demand.

Differentiation must be faster, smaller and more flexible: distributed suites, common safety and procurement, shared high-cost equipment, transparent availability and a guaranteed expansion pathway across partner buildings.

The opportunity

A managed network of modular Category 1/2-ready labs and write-up space in partner buildings. Members can start with a bench or small private suite, book shared equipment, access waste and consumables services, and move across the network as they grow.

A digital layer manages compliance, training, equipment, availability, billing and referrals to funding, talent and research partners.

Commercial model

Pricing classification

Proxy based — medium confidence.

Indicative pricing

- Paid test offer: Paid portfolio pilot: £10,000–£30,000 Illustrative commercial model, benchmarked against a UK advertised shared-lab rate from £1,400 per month: - Shared wet-lab bench: £1,250-£2,000 per month including core services. - Private Category 2-ready suite: £45-£80 per square foot per year plus service charge, subject to building and fit-out. - Onboarding and safety validation: £1,000-£5,000 per company. - Specialist equipment membership: £250-£1,500 per month or metered use. - Landlord management fee: 8%-15% of gross licence revenue, with separate fit-out funding.

Evidence basis: EpiCentre Haverhill - Shared lab pricing benchmark (Linked pricing/rate page; no exact comparable price was extracted for this review) is the closest verified adjacent anchor used here. Its buyer, duration and scope are not assumed to be identical; implementation is separated where the opportunity requires integration, assurance or managed delivery.

Commercial test

Ask one council, housing provider, developer, asset owner or property adviser to fund a paid test of Liverpool Flexible Lab and Grow-On Network lasting 8–12 weeks, using an opening price of £10,000–£30,000 and covering 20 live properties, placements, applications or asset decisions. Paid scope: A managed network of modular Category 1/2-ready labs and write-up space in partner buildings. Charge by organisation, property portfolio, site or completed assessment and compare the fee with manual property screening, placement, inspection, reconciliation and external-adviser effort. Measure case or placement time, data completeness, rework, unsuitable outcomes, adviser hours and decision conversion. Continue only if handling time or rework falls by at least 25%, quality checks are passed and the buyer commits to the next portfolio period. Stop or reprice if the tool duplicates incumbent housing software, worsens a placement/decision or does not save enough effort to cover the fee.

Monetisation models and pricing estimates are research-informed and indicative only. Where direct pricing evidence is unavailable, estimates may use comparable products, procurement data, adjacent market benchmarks and stated assumptions. They are not financial advice, forecasts or guarantees of commercial viability. Independent market, legal and financial validation is recommended before acting.

Score rationale

Underserved score 85/100

Evidence 25/25 + severity 18/20 + buyer urgency 16/20 + market gap 12/15 + timing 9/10 + delivery feasibility 5/10 = 85/100. Confidence is 85/100 because quantified need and a funding route are explicit and market pricing exists; capital intensity, technical feasibility and pre-commitment remain material unknowns.

The score is evidence-informed editorial judgement based on manually reviewed sources. It is not a forecast or guarantee. How we score →

Evidence sources8

Some evidence sources may require an account or sign-in to view the original content.